Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Safety Study for the Treatment of Abdominal Aortic Aneurysms

ClinicalTrials.gov ID: NCT00610090

Public ClinicalTrials.gov record NCT00610090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Single-arm, Prospective Study of the Safety of the UniFit Aorto-uni-iliac Endoluminal Stent Graft for the Repair of Abdominal Aortic Aneurysms

Study identification

NCT ID
NCT00610090
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Duke Vascular, Inc.
Industry
Enrollment
71 participants

Conditions and interventions

Interventions

  • UniFit AAA Stent Graft Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2007
Primary completion
Nov 30, 2015
Completion
Nov 30, 2015
Last update posted
Aug 24, 2015

2007 – 2015

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Loma Linda VA Loma Linda California 92354
UCLA Medical Center Torrance California 90502
Christiana Hospital Newark Delaware 19713
Florida Hospital Orlando Florida 32803
Sacred Heart Hospital Pensacola Florida 32504
Emory University Atlanta Georgia 30322
Savannah Vascular Institute Savannah Georgia 31404
Indiana University Hospital Indianapolis Indiana 46206
Iowa Heart Center Des Moines Iowa 50266
University of Massachusetts Medical School Worcester Massachusetts 01655
William Beaumont Hospital Royal Oak Michigan 48073
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
Englewood Hospital Englewood New Jersey 07631
Albany Medical Center Hospital Albany New York 12208
Dotter Interventional Institute Portland Oregon 97239
Scott and White Hospital Temple Texas 76508
Inova Fairfax Hospital Fairfax Virginia 22042
Sentara Healthcare, Vascular and Transplant Specialists Norfolk Virginia 23507
Southwest Washington Medical Center Vancouver Washington 98664

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00610090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2015 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00610090 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →